To investigate whether HSPB1 can alter breast cancer cell tumor biology, a series of in vitro experiments were performed in MDA-MB-231 and MDA-MB-468 cell lines overexpressing HSPB1 or with HSPB1 knockdown. Here, HSPB1 is linked to breast carcinoma.